Pharmacy News and Research

RSS

Community pharmacy, also known as retail pharmacy, is the most common type of pharmacy that allows the public access to their medications and advice about their health. Traditionally known as a chemist, it is the healthcare facility that is responsible for the provision of pharmaceutical service to a specific community group or region.

Research findings could help inform more effective therapies for AML

Acute myeloid leukemia (AML) is a type of cancer in which the bone marrow makes a large number of abnormal blood cells. It is the most common type of acute leukemia in adults.

24 Apr 2023

Study explores the culture of antibiotic prescribing in US hospital ICUs

In the United States, physicians in almost every specialty and role use antibiotics as part of their therapeutic armamentariums.

20 Apr 2023

Will they or won’t they (block the abortion pill)?

Supreme Court justices could act at any moment on access to the abortion pill mifepristone. Beyond reproductive health, their ruling could carry significant implications for states' rights and FDA independence and integrity.

20 Apr 2023

UWaterloo expert helps develop database repository to manage treatment for hemophilia patients

Today is World Hemophilia Day under the theme ‘Access for all: prevention of bleeds as the global standard of care’. Dr. Andrea Edginton, Hallman Director at the University of Waterloo School of Pharmacy, uses her research to help pharmacists, doctors and nurses manage treatment for hemophilia patients that has, in turn, helped these patients lead a better quality of life.

18 Apr 2023

The confusing fate of the abortion pill

The abortion pill mifepristone is now ground zero in the abortion debate.

13 Apr 2023

Research highlights new technique for measuring cardiac risk related to cobalt-containing hip replacements

A technique for measuring the cardiac risk associated with cobalt-containing hip replacements has been highlighted for the first time in research at the University of Strathclyde.

13 Apr 2023

The drug company that prospered without creating any drugs

The new drug looked so promising — except for that one warning sign.

13 Apr 2023

Placebo in addition to methadone shown to be feasible treatment for opioid use disorder

There were more than 100,000 reported deaths from opioid overdoses in 2021, according to the Centers for Disease Control and Prevention.

12 Apr 2023

New approach identifies significant molecular changes linked to pediatric bipolar disorder

It's extremely difficult to study the biological basis of psychiatric disorders, in part because researchers can't easily collect brain cells from living people to study in the laboratory. Now, University of Utah Health scientists have developed a way around that.

12 Apr 2023

MUSC study reveals the two most important factors driving COVID-19 vaccine hesitancy

South Carolina residents were more hesitant than Americans as a whole to receive the COVID-19 vaccine during the fall of 2020, report researchers in the Department of Psychiatry and Behavioral Sciences at the Medical University of South Carolina in the Journal of Psychiatry Research.

11 Apr 2023

Study to measure the impact of whole genome sequencing in patients with cardiovascular disease

Henry Ford Health research teams are launching a series of clinical studies in partnership with Illumina Inc., a global leader in DNA sequencing and array-based technologies, to assess the impact of comprehensive genomic testing in various disease areas.

11 Apr 2023

UH researcher examines the causes of skeletal muscle atrophy

Skeletal muscle atrophy, or wasting, is a devastating and often irreversible syndrome during the aging process and for patients with advanced cancer.

11 Apr 2023

Lack of therapeutic markers leads to poorer outcomes in triple negative breast cancer

A new review paper was published in Oncotarget's Volume 14 on March 31, 2023, entitled, "Crosstalk between triple negative breast cancer and microenvironment."

10 Apr 2023

Innovative statewide surveillance system will help reduce the burden of opioid use disorder in Kentucky

University of Kentucky researchers are creating an innovative statewide surveillance system to inform prevention and response efforts aimed at reducing the burden of opioid use disorder in Kentucky.

10 Apr 2023

Genetic discovery may pave the way for precision medicine approaches to treat depression

A team of scientists at the Medical University of South Carolina (MUSC) has identified a stress-regulated gene that plays a role in the link between long-term stress and a common type of depressive behavior in mice.

7 Apr 2023

Leveraging cell self-destruction to treat glioblastoma tumors

Glioblastoma is the most common type of brain tumor in adults. The disease is 100% fatal and there are no cures, making it the most aggressive type of cancer. Such a poor prognosis has motivated researchers and neurosurgeons to understand the biology of tumors with the goal of creating better therapies.

7 Apr 2023

$1 million NIH grant to support UTEP's transformative pancreatic cancer research

The University of Texas at El Paso will undertake potentially transformative research on how specific risk factors promote pancreatic cancer development with support from a $1 million grant from the National Institutes of Health's National Cancer Institute.

6 Apr 2023

Gov. Newsom wanted California to cut ties with Walgreens. Then federal law got in the way.

Gov. Gavin Newsom declared last month that California was "done" doing business with Walgreens after the pharmacy chain said it would not distribute an abortion pill in 21 states where Republicans threatened legal action. Since then, KHN has learned that the Democratic governor must compromise on his hard-line tweet.

6 Apr 2023

Oral antiviral CD04872SC shows promise in neutralizing COVID-19 variants, offering hope for broad-spectrum treatment

Researchers discover a small molecule drug candidate that could provide immediate protection against infection with SARS-CoV-2.

4 Apr 2023

Spike protein could be responsible for memory loss in post-COVID-19 syndrome

Patients diagnosed with post-COVID-19 syndrome often experience cognitive and memory impairments. A new study by researchers from the Federal University of Rio de Janeiro (UFRJ) and UniRio provides insight into the mechanism behind this phenomenon.

3 Apr 2023

Pharmacy News and Research

Further Reading

Research findings could help inform more effective therapies for AML

Study explores the culture of antibiotic prescribing in US hospital ICUs

Will they or won’t they (block the abortion pill)?

UWaterloo expert helps develop database repository to manage treatment for hemophilia patients

The confusing fate of the abortion pill

Research highlights new technique for measuring cardiac risk related to cobalt-containing hip replacements

The drug company that prospered without creating any drugs

Placebo in addition to methadone shown to be feasible treatment for opioid use disorder

New approach identifies significant molecular changes linked to pediatric bipolar disorder

MUSC study reveals the two most important factors driving COVID-19 vaccine hesitancy

Study to measure the impact of whole genome sequencing in patients with cardiovascular disease

UH researcher examines the causes of skeletal muscle atrophy

Lack of therapeutic markers leads to poorer outcomes in triple negative breast cancer

Innovative statewide surveillance system will help reduce the burden of opioid use disorder in Kentucky

Genetic discovery may pave the way for precision medicine approaches to treat depression

Leveraging cell self-destruction to treat glioblastoma tumors

$1 million NIH grant to support UTEP's transformative pancreatic cancer research

Gov. Newsom wanted California to cut ties with Walgreens. Then federal law got in the way.

Oral antiviral CD04872SC shows promise in neutralizing COVID-19 variants, offering hope for broad-spectrum treatment

Spike protein could be responsible for memory loss in post-COVID-19 syndrome

Drug Discovery - Second Edition eBook

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News